Published on by Environmental Scientists
49 / 100
Powered by Rank Math SEO
SEO Score

Dr. Maria Gontika | Neuroimmunology | Best Scholar Award

Penteli’s Children Hospital | Greece

Dr. Maria Gontika is a neurologist and pediatric neurologist whose research and clinical expertise span neuroimmunology, pediatric multiple sclerosis, demyelinating disorders, neuroimaging, and complex neurogenetic conditions in children, with 104 citations by 81 documents, 13 documents, and an h-index of 7. Her work integrates clinical neurology with immunogenetics, contributing significant insights into disease mechanisms, biomarkers, and therapeutic responses in pediatric neuroimmune disorders. She has extensively investigated pediatric-onset multiple sclerosis in Hellenic cohorts, focusing on immunogenetic variants, clinical characteristics, neuroimaging correlations, and factors influencing treatment success. Her publications highlight the impact of HLA alleles, the spectrum of autoimmune encephalitis presentations, and the growing recognition of MOG antibody–associated diseases in children. She has evaluated real-world outcomes of disease-modifying therapies such as natalizumab and fingolimod, offering valuable perspectives on their immunological effects, long-term safety, and the importance of early intervention. Her scholarly contributions also include detailed case reports and series addressing rare neuroimmune manifestations, infantile epileptic spasms, and genetic determinants of neurodevelopmental disorders. In addition to research, she is actively engaged in scientific dissemination as a guest editor for a special issue on immune-mediated neurological disorders and as a reviewer for high-impact international journals, supporting rigorous evaluation and advancement of pediatric neuroimmunology literature. Her participation in collaborative clinical studies and international trials further demonstrates her commitment to translational research and the development of evidence-based therapeutic approaches. Through her combined roles as clinician, researcher, and scientific contributor, she continues to advance the understanding and management of complex neurological disorders in children, promoting improved diagnostic accuracy, personalized treatment strategies, and long-term patient outcomes.

Featured Publications

Smyrni, N., Koutsaki, M., Petra, M., Nikaina, E., Gontika, M., Strataki, H., Davora, F., Bouza, H., Damianos, G., Skouteli, H., Mastroyianni, S., Dalivigka, Z., Dinopoulos, A., & Papavasiliou, A. (2021). Moderately and late preterm infants: short-and long-term outcomes from a registry-based cohort. Frontiers in Neurology, 12, 628066.

Skarlis, C., Gontika, M., Katsavos, S., Velonakis, G., Toulas, P., & Anagnostouli, M. (2017). Multiple sclerosis and subsequent human immunodeficiency virus infection: A case with the rare comorbidity, focus on novel treatment issues and review of the literature. In Vivo, 31(5), 1041–1046.

Gontika, M. P., Konialis, C., Pangalos, C., & Papavasiliou, A. (2017). Novel SCN1A and GABRA1 gene mutations with diverse phenotypic features and the question on the existence of a broader spectrum of Dravet syndrome. Child Neurology Open, 4, 2329048X17706794.

Gontika, M. P., & Anagnostouli, M. C. (2018). Anti-myelin oligodendrocyte glycoprotein and human leukocyte antigens as markers in pediatric and adolescent multiple sclerosis: On diagnosis, clinical phenotypes, and therapeutic responses. Multiple Sclerosis International, 2018(1), 8487471.

Anagnostouli, M., Artemiadis, A., Gontika, M., Skarlis, C., Markoglou, N., Zalonis, I., … & Kararizou, E. (2020). HLA-DPB103 as risk allele and HLA-DPB104 as protective allele for both early- and adult-onset multiple sclerosis in a Hellenic cohort. Brain Sciences, 10(6), 374.

 

Maria Gontika | Neuroimmunology | Best Scholar Award

You May Also Like